A 12 amino acid sequence from the adenovirus 12 E1B protein is homologous at the protein level with a similar 12-mer derived from the wheat protein A-gliadin.
derived from the wheat protein A-gliadin. It has been suggested that exposure to Ad 12 could sensitise individuals to gliadins with resultant gluten sensitive enteropathy. In this study, the polymerase chain reaction (PCR) was used to analyse duodenal biopsy tissue from patients with coeliac disease for the presence of Ad 12.
The sensitivity of the assay system was at least 1 in 105 cells and specificity was confirmed both by probing with an internal oligonucleotide and by direct sequencing. Ad 12 sequences were detected in three of 17 patients with adult coeliac disease and in five of 16 adult controls with normal duodenal biopsies. Since exposure to the virus would be predicted to occur in infancy we also studied patients with childhood coeliac disease diagnosed at less than 1 year of age. Ad 12 was positive in three of 10 childhood coeliac patients and one of seven controls. In addition, we studied a cohort of patients who presented with a diarrhoeal illness and associated anti a gliadin antibodies in 1983. These patients had duodenal biopsies performed at this time. One of three patients with abnormal histology had detectable Ad 12 while two of 14 with normal findings were positive for Ad 12. Finally, the potential oncogenic nature of Ad 12 prompted examination of a group of patients with intestinal tumours. Ad 12 DNA was, however, in only two of 19 tumour samples tested. These data indicate that Ad 12 can be successfully detected using PCR on paraffin embedded tissue. Furthermore, Ad 12 was detected at a relatively high level in normal duodenum. The results do not, however, support the hypothesis that prior exposure to Ad 12 is implicated in the pathogenesis of coeliac disease. (Gut 1994; 35: [1226] [1227] [1228] [1229] [1230] [1231] [1232] Coeliac disease is a gluten sensitive enteropathy characterised by intestinal villous atrophy in response to dietary gluten. The disease is HLA linked and is tightly associated with HLA antigens including HLA Al, B8, DR3, and DQ2.1 2 In addition, an association with HLA DP 3.1 and 4 2 haplotypes has been described.3 Since these molecules are involved directly in the processing and presentation of antigen to T cells, it has been proposed that coeliac disease is a T cell mediated disease with antigenic recognition of linear segments on the gluten peptides. 1 4 The alcohol soluble fractions of gluten are called gliadins and include a, P, y, w gliadins on the basis of electrophoretic shift. All of these fractions are known to precipitate the activity of coeliac disease but it has been suggested that a gliadin is more potent both in inducing disease and in inducing an antibody response. Preparation ofgenetic material A number of sections (3 mm) were cut from each block using a new knife for each block to avoid cross contamination. Samples were dewaxed using mixed xylenes and DNA was extracted using a modified proteinase K/SDS method as previously described.'2 Samples were prepared in a separate area from DNA amplification as a precaution against contamination.
PCR
All amplifications were performed in a 50 gl reaction volume using conditions already described.'3 For nested PCR, excess primers and dNTPs were removed from first round PCR by centrifugation through spin columns. Some 2 ,ul of the initial amplification product were then subjected to second round amplification using internal primers (Fig 1) . In order to examine the sensitivity of the assay system, serial dilution of BMK cells in Ad 12 negative human neutrophils was performed. Cells were then pelleted, formalin fixed, and paraffin embedded. Sections through these cell blocks were then dewaxed, DNA extracted, and subjected to 30 cycles of amplification. For all amplifications, the procedures recommended by Kwok and Higuchil4 were followed to avoid contamination.
Restriction enzyme digestion The Alu 1 enzyme is predicted to cut the amplified sequence in two fragments of known molecular weight, 67 bp and 82 bp and allowed confirmation of the identity of the amplified product. In addition, we also performed restriction digests with Pvu 11 (which overlaps the Alu 1 site) and Sau lila, which yields fragments of 71 and 78 bp. All (Fig 2) . The specificity of the amplification was confirmed by cleavage of the amplified fragment using the restriction enzyme Alu 1 into two fragments of 67 bp and 82 bp, as predicted from the location of the Alu 1 site in the nucleotide sequence of the published Ad 12 sequence (Figs 1 and 3 ). In addition, the restriction enzymes Sau llla (Fig 3) (Table II) . In all cases these sequences were detected using Ad 12 specific primers. An example of the results achieved is shown in Figure 4 (A). However, Ad 12 sequences were also detected in five of 16 patients with normal duodenal biopsy tissues (Table II, Fig 4(B) ). Dot blots were probed in duplicate with Ad 12 Ela probe and rhodopsin probe as a positive control. PCR analysis had revealed three positive signals in coeliac patients by ethidium bromide staining (Fig 4(A), lanes 7, 9, and 10) . These all proved positive on dot blot analysis (column C rows 1, 3, and 4). A fourth sample which had been negative by ethidium bromide staining provedfaintly positive by dot blot analysis (column C row 2) but a subsequent biopsy proved negative (column C row 5). Therefore, this sample has not been included as a positive result in the final analysis.
gastrointestinal tract. All but one of these samples was negative. It is notable, however, that two patients who had Ad 12 sequences detected in the duodenum did not have these sequences present in concomitant gastric biopsy specimens. Ad 12 positive cells were confirmed in all cases by oligonucleotide hybridisation of amplified DNA (Fig 5) . AD 
DETECTION IN CHILDHOOD COELIAC

PATIENTS
Ad 12 was detected in duodenal biopsy specimens from three of 10 coeliac patients diagnosed within the first year of life. Ad 12 was also detected in one of seven normal duodenal biopsies performed during the first year of life (Table II) . AD 
DETECTION IN CHILDREN WITH ANTIBODIES TO eL GLIADIN
All of these children with antibodies to a gliadin (Table I) were subsequently followed up and had at least one duodenal biopsy. Two patients were found to have villous atrophy consistent with coeliac disease and a further case had a significant increase in the intraepithelial lymphocyte count. PCR amplification detected Ad 12 sequences in two of these children with normal biopsies and one of three with abnormal biopsies (Table I) . There was no correlation between the anti-a gliadin antibody titres and the presence or absence of Ad 12 DNA. AD 
DETECTION IN PATIENTS WITH INTESTINAL ADENOCARCINOMAS
Since Ad 12 has been reported to be oncogenic, we also examined material from a range of intestinal adenocarcinomas for Ad 12 DNA. Briefly, Ad 12 DNA was detected in none of nine colorectal carcinoma samples, none of four ampullary carcinoma samples and in two of five duodenal carcinoma samples tested. Thus, in total two of 19 tumour samples tested were positive for Ad 12 DNA.
DNA extraction and PCR amplification was achieved from all samples in the study with the exception of those that had been fixed with Bouin's fluid. Extension of proteinase k digestion times and a variety of modifications in the extraction protocol did not yield material of a sufficient quality for routine PCR. Since the concept of molecular mimicry could also include the possibility that infection during childhood with subsequent eradication of viral antigen might permit recognition of the gliadin peptide in later life, we also examined the duodenal biopsy specimens of patients with coeliac disease detected during the first year of life, and frequently during the first 6 months. In these cases, the incidence of Ad 12 detection did not differ significantly from the adult incidence of Ad 12. Nor did Ad 12 positivity correlate significantly with anti-ot gliadin antibody detection in infants with diarrhoeal illness. These data suggest that Ad 12 is not associated with the development of coeliac disease. It is still possible that infection in very early infancy could result in disease. However, given the very high rate of detection of this sequence, it suggests a relatively high prevalence of the virus. The prevalence seems to be similar in both adults and children suggesting that infection occurs at a very young age.
In view of the documented high prevalence of El A sequences, we were concerned that this oncogenic virus might be associated with tumour In this study we have not observed any association between the presence of Ad 12 ElA DNA and the development of carcinoma of the gastrointestinal tract in humans.
PCR of paraffin embedded material is a robust technique and has been useful in the assessment of archival material.'2 22 The lack of amplification seen in this study from any material that had been previously fixed with Bouin's fluid makes us recommend that this fixative is not used in material that may subsequently be needed for DNA analysis. A recent study has identified Ad 12 in both adult and childhood duodenal biopsy tissues. 23 The current study differs from both that study and the other study previously described8 in that ElA DNA sequences were studied. Secondly, the assay system was adapted for high sensitivity with paraffin embedded tissue. Furthermore, we have confirmed: (i) that Ad 12 is not present in newly diagnosed coeliac patients less than 1 year of age and (ii) that anti-gliadin antibodies may be detected in infantile diarrhoeal illnesses which are not associated with adenovirus 12. These data indicate that cross reactivity to Ad 12 is not implicated in anti-gliadin antibody generation in children and secondly that Ad 12 is not implicated in the continuing pathogenesis of infantile coeliac disease. One cannot, however, entirely exclude the possibility that brief infection of the neonate without integration might serve as an initiation event for coeliac disease. Since Ad 12 positivity is not uncommon in our patient population, in agreement with previous serological and molecular studies,6 8 23 this makes it unlikely that Ad 12 is implicated in the pathogenesis of coeliac disease.
